Abstract
According to “free-radical theory” of disease, Reactive Oxygen Species (ROS) play a key role in the pathogenesis of several diseases including cardiovascular disease. When the balance between production of free radicals and antioxidant capacity of the cardiac cells is altered due to pathophysiological conditions, oxidative stress is induced. Oxidative stress has been linked to the development of ischemic heart disease, atherosclerosis, congestive heart failure, ischemic-reperfusion injury, and vascular endothelial dysfunction. In this context, antioxidant supplementation would have a positive effect on cardiovascular diseases. However, several clinical trials over the past decades employed different strategies of antioxidant therapies which have failed to achieve favorable results in ameliorating or preventing cardiovascular diseases. Much less attention has been paid to the modulation of ROS production, despite the fact that prevention, rather than cure, would appear to be a logic approach to attenuate the oxidative damage. This chapter intends to highlight the mechanisms of oxidative stress modulation – by Natural or induced mitochondrial uncoupling respiration – in regulating ROS production and its significance in cardiovascular pathophysiological conditions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mootha VK, Arai AE, Balaban RS (1997) Maximum oxidative phosphorylation capacity of the mammalian heart. Am J Phys Heart Circ Phys 272(2):H769–H775
Brand MD, Esteves TC (2005) Physiological functions of the mitochondrial uncoupling proteins UCP2 and UCP3. Cell Metab 2(2):85–93
NICHOLLS DG (1974) The influence of respiration and ATP hydrolysis on the proton-electrochemical gradient across the inner membrane of rat-liver mitochondria as determined by ion distribution. Eur J Biochem 50(1):305–315
Rolfe DF et al (1999) Contribution of mitochondrial proton leak to respiration rate in working skeletal muscle and liver and to SMR. Am J Phys Cell Phys 276(3):C692–C699
MacLellan JD et al (2005) Physiological increases in uncoupling protein 3 augment fatty acid oxidation and decrease reactive oxygen species production without uncoupling respiration in muscle cells. Diabetes 54(8):2343–2350
Miller D, MacFarlane N (1995) Intracellular effects of free radicals and reactive oxygen species in cardiac muscle. J Hum Hypertens 9(6):465–473
Thannickal VJ, Fanburg BL (2000) Reactive oxygen species in cell signaling. Am J Phys Lung Cell Mol Phys 279(6):L1005–L1028
Cannon B, Hedin A, Nedergaard J (1982) Exclusive occurrence of thermogenin antigen in brown adipose tissue. FEBS Lett 150(1):129–132
Akhmedov AT, Rybin V, Marín-García J (2015) Mitochondrial oxidative metabolism and uncoupling proteins in the failing heart. Heart Fail Rev 20(2):227–249
Schrauwen P (2004) The role of uncoupling protein 3 in fatty acid metabolism: protection against lipotoxicity? Proc Nutr Soc 63(2):287–292
Cardaci S, Filomeni G, Ciriolo MR (2012) Redox implications of AMPK-mediated signal transduction beyond energetic clues. J Cell Sci 125(9):2115–2125
Putman CT et al (2003) AMPK activation increases uncoupling protein-3 expression and mitochondrial enzyme activities in rat muscle without fibre type transitions. J Physiol 551(1):169–178
Xie Z et al (2008) Up-regulation of mitochondrial uncoupling protein-2 by the AMP-activated protein kinase in endothelial cells attenuates oxidative stress in diabetes. Diabetes 57:3222
DIRAISON F et al (2004) Over-expression of sterol-regulatory-element-binding protein-1c (SREBP1c) in rat pancreatic islets induces lipogenesis and decreases glucose-stimulated insulin release: modulation by 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR). Biochem J 378(3):769–778
Kozak UC et al (1994) An upstream enhancer regulating brown-fat-specific expression of the mitochondrial uncoupling protein gene. Mol Cell Biol 14(1):59–67
Reddy JK, Krishnakantha T (1975) Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate. Science 190(4216):787–789
Lehmann JM et al (1997) Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J Biol Chem 272(6):3406–3410
YOUNG ME et al (2001) Uncoupling protein 3 transcription is regulated by peroxisome proliferator-activated receptor α in the adult rodent heart. FASEB J 15(3):833–845
Gilde AJ et al (2003) Peroxisome proliferator-activated receptor (PPAR) α and PPARβ/δ, but not PPARγ, modulate the expression of genes involved in cardiac lipid metabolism. Circ Res 92(5):518–524
Barger PM, Kelly DP (2000) PPAR signaling in the control of cardiac energy metabolism. Trends Cardiovasc Med 10(6):238–245
Murray AJ et al (2004) Uncoupling proteins in human heart. Lancet 364(9447):1786–1788
Williamson J, Krebs H (1961) Acetoacetate as fuel of respiration in the perfused rat heart. Biochem J 80(3):540
Murray AJ et al (2005) Plasma free fatty acids and peroxisome proliferator–activated receptor α in the control of myocardial uncoupling protein levels. Diabetes 54(12):3496–3502
Parameswaran N, Patial S (2010) Tumor necrosis factor-α signaling in macrophages. Crit Rev Eukaryot Gene Expr 20(2):87
Busquets Sl et al (1998) In the rat, tumor necrosis factor α administration results in an increase in both UCP2 and UCP3 mRNAs in skeletal muscle: a possible mechanism for cytokine-induced thermogenesis? FEBS Lett 440(3):348–350
Lee FJ et al (1999) Tumor necrosis factor increases mitochondrial oxidant production and induces expression of uncoupling protein-2 in the regenerating rat liver. Hepatology 29(3):677–687
Kwon HJ et al (2003) Case reports of heart failure after therapy with a tumor necrosis factor antagonist. Ann Intern Med 138(10):807–811
Moore KJ, Tabas I (2011) Macrophages in the pathogenesis of atherosclerosis. Cell 145(3):341–355
Chang M-C et al (2017) Lysophosphatidylcholine induces cytotoxicity/apoptosis and IL-8 production of human endothelial cells: Related mechanisms. Oncotarget 8(63):106177
Lee K-U et al (2005) Effects of recombinant adenovirus-mediated uncoupling protein 2 overexpression on endothelial function and apoptosis. Circ Res 96(11):1200–1207
Alves-Guerra JBMM et al. Protective Role of Uncoupling Protein 2 in Atherosclerosis
Braganza D, Bennett M (2001) New insights into atherosclerotic plaque rupture. Postgrad Med J 77(904):94–98
Jennings RB, Ganote CE (1974) Structural changes in myocardium during acute ischemia. Circ Res 35(3_supplement):III-156–III-172
Rechavia E et al (1995) Hyperdynamic performance of remote myocardium in acute infarction: Correlation between regional contractile function and myocardial perfusion. Europ Heart J 16(12):1845–1850
Almsherqi ZA et al (2006) Reduced cardiac output is associated with decreased mitochondrial efficiency in the non-ischemic ventricular wall of the acute myocardial-infarcted dog. Cell Res 16(3):297
Murray AJ et al (2008) Increased mitochondrial uncoupling proteins, respiratory uncoupling and decreased efficiency in the chronically infarcted rat heart. J Mol Cell Cardiol 44(4):694–700
Gottlieb RA et al (1994) Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94(4):1621–1628
Almsherqi ZA et al (2006) Displacement of the beating heart induces an immediate and sustained increase in myocardial reactive oxygen species. Circ J 70(9):1226–1228
Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74(5):1124–1136
Liu Y et al (2009) Both ischemic preconditioning and ghrelin administration protect hippocampus from ischemia/reperfusion and upregulate uncoupling protein-2. BMC Physiol 9(1):17
Bienengraeber M, Ozcan C, Terzic A (2003) Stable transfection of UCP1 confers resistance to hypoxia/reoxygenation in a heart-derived cell line. J Mol Cell Cardiol 35(7):861–865
Organisation WH (2017) The top 10 causes of death
Misaka T et al (2018) FKBP8 protects the heart from hemodynamic stress by preventing the accumulation of misfolded proteins and endoplasmic reticulum-associated apoptosis in mice. J Mol Cell Cardiol 114:93–104
Cappetta D et al (2017) Effects of ranolazine in a model of doxorubicin-induced left ventricle diastolic dysfunction. Br J Pharmacol 174(21):3696–3712
Bugger H et al (2011) Uncoupling protein downregulation in doxorubicin-induced heart failure improves mitochondrial coupling but increases reactive oxygen species generation. Cancer Chemother Pharmacol 67(6):1381–1388
Jiménez-Jiménez J et al (2006) Fatty acid activation of the uncoupling proteins requires the presence of the central matrix loop from UCP1. Biochimica et Biophysica Acta (BBA)-Bioenergetics 1757(9–10):1292–1296
Teshima Y et al (2003) Uncoupling protein-2 overexpression inhibits mitochondrial death pathway in cardiomyocytes. Circ Res 93(3):192–200
Perrino C et al (2013) Genetic deletion of uncoupling protein 3 exaggerates apoptotic cell death in the ischemic heart leading to heart failure. J Am Heart Assoc 2(3):e000086
Gaussin V et al (2003) Common Genomic Response in Different Mouse Models of β-Adrenergic–Induced Cardiomyopathy. Circulation 108(23):2926–2933
Hang T et al (2007) Apoptosis and expression of uncoupling protein-2 in pressure overload-induced left ventricular hypertrophy. Acta Cardiol 62(5):461–465
Ji X-B et al (2015) Inhibition of uncoupling protein 2 attenuates cardiac hypertrophy induced by transverse aortic constriction in mice. Cell Physiol Biochem 36(5):1688–1698
Murakami K et al (2002) Perindopril effect on uncoupling protein and energy metabolism in failing rat hearts. Hypertension 40(3):251–255
Sack MN (2006) Mitochondrial depolarization and the role of uncoupling proteins in ischemia tolerance. Cardiovasc Res 72(2):210–219
Hesselink MK, Schrauwen P (2005) Uncoupling proteins in the failing human heart: friend or foe? Lancet 365(9457):385–386
Russell RR et al (2004) AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J Clin Invest 114(4):495–503
Pierelli G et al (2017) Uncoupling protein 2: a key player and a potential therapeutic target in vascular diseases. Oxidative Med Cell Longev 2017:1
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Almsherqi, Z.A., Li, B.Y.H., Zhou, Y., McLachlan, C.S. (2019). Modulation of Oxidative Stress in Heart Disease by Uncoupling Proteins. In: Chakraborti, S., Dhalla, N., Dikshit, M., Ganguly, N. (eds) Modulation of Oxidative Stress in Heart Disease. Springer, Singapore. https://doi.org/10.1007/978-981-13-8946-7_1
Download citation
DOI: https://doi.org/10.1007/978-981-13-8946-7_1
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-8945-0
Online ISBN: 978-981-13-8946-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)